ATE477321T1 - Aviäre telomerase reverse transkriptase - Google Patents

Aviäre telomerase reverse transkriptase

Info

Publication number
ATE477321T1
ATE477321T1 AT07703676T AT07703676T ATE477321T1 AT E477321 T1 ATE477321 T1 AT E477321T1 AT 07703676 T AT07703676 T AT 07703676T AT 07703676 T AT07703676 T AT 07703676T AT E477321 T1 ATE477321 T1 AT E477321T1
Authority
AT
Austria
Prior art keywords
telomerase reverse
aviary
reverse transcriptase
cells
nucleic acid
Prior art date
Application number
AT07703676T
Other languages
English (en)
Inventor
Philippe Erbs
Jean-Marc Balloul
Marina Kapfer
Nathalie Silvestre
Original Assignee
Transgene Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Transgene Sa filed Critical Transgene Sa
Application granted granted Critical
Publication of ATE477321T1 publication Critical patent/ATE477321T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1241—Nucleotidyltransferases (2.7.7)
    • C12N9/1276—RNA-directed DNA polymerase (2.7.7.49), i.e. reverse transcriptase or telomerase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT07703676T 2006-01-05 2007-01-05 Aviäre telomerase reverse transkriptase ATE477321T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP06360001 2006-01-05
EP06360047 2006-10-13
PCT/EP2007/050120 WO2007077256A1 (en) 2006-01-05 2007-01-05 Avian telomerase reverse transcriptase

Publications (1)

Publication Number Publication Date
ATE477321T1 true ATE477321T1 (de) 2010-08-15

Family

ID=38016619

Family Applications (1)

Application Number Title Priority Date Filing Date
AT07703676T ATE477321T1 (de) 2006-01-05 2007-01-05 Aviäre telomerase reverse transkriptase

Country Status (19)

Country Link
US (1) US9024003B2 (de)
EP (1) EP1979474B1 (de)
JP (2) JP5661243B2 (de)
KR (1) KR101337377B1 (de)
CN (1) CN102268413A (de)
AT (1) ATE477321T1 (de)
AU (1) AU2007204024B2 (de)
BR (1) BRPI0706836B1 (de)
CA (1) CA2636329C (de)
CY (1) CY1110860T1 (de)
DE (1) DE602007008360D1 (de)
DK (1) DK1979474T3 (de)
HR (1) HRP20100484T1 (de)
PL (1) PL1979474T3 (de)
PT (1) PT1979474E (de)
RS (1) RS51525B (de)
RU (1) RU2415867C2 (de)
SI (1) SI1979474T1 (de)
WO (1) WO2007077256A1 (de)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL1979474T3 (pl) * 2006-01-05 2011-01-31 Transgene Sa Ptasia odwrotna transkryptaza o charakterze telomerazy
EP1985305A1 (de) * 2007-04-24 2008-10-29 Vivalis Aus Entenembryonen gewonnene Stammzellkulturen zur Herstellung von Impfstoffen gegen Viren
US8357531B2 (en) * 2007-07-03 2013-01-22 Transgene S.A. Immortalized avian cell lines
KR101014030B1 (ko) 2008-08-29 2011-02-14 현대자동차주식회사 와이어링 취부용 플랜지 및 제조공정
US8609392B2 (en) * 2009-05-12 2013-12-17 Transgene S.A. Method for orthopoxvirus production and purification
EP2531592A1 (de) 2010-02-04 2012-12-12 Vivalis Fed-batch-verfahren mit konzentriertem zellkulturmedium zur effizienten produktion von biologischen wirkstoffen bei eb66-zellen
WO2012095514A1 (en) 2011-01-14 2012-07-19 Vivalis Recombinant protein production system
EP2724157B1 (de) 2011-06-27 2017-03-08 Valneva Screening-verfahren für zellen
TW201318637A (zh) 2011-09-29 2013-05-16 Transgene Sa 免疫療法組成物及用於治療ｃ型肝炎病毒感染之療程（一）
WO2013045668A2 (en) 2011-09-29 2013-04-04 Transgene Sa Immunotherapy composition and regimen for treating hepatitis c virus infection
KR102507483B1 (ko) 2014-12-01 2023-03-07 트랜스진 안정한 액체 백시니아 바이러스 제제
US10428316B2 (en) 2014-12-04 2019-10-01 Intervet Inc. Immortalised chicken embryo fibroblasts
EP4523756A3 (de) 2015-02-13 2025-05-28 Transgene Immunotherapeutischer impfstoff und antikörperkombinationstherapie
CA3023022A1 (en) 2016-05-04 2017-11-09 Transgene Sa Combination therapy with cpg tlr9 ligand
WO2018069316A2 (en) 2016-10-10 2018-04-19 Transgene Sa Immunotherapeutic product and mdsc modulator combination therapy
EP3624851A1 (de) 2017-05-15 2020-03-25 Janssen Vaccines & Prevention B.V. Stabile virushaltige zusammensetzung
CA3062549A1 (en) 2017-05-15 2018-11-22 Janssen Vaccines & Prevention B.V. Stable virus-containing composition
WO2018234506A2 (en) 2017-06-21 2018-12-27 Transgene Sa PERSONALIZED VACCINE
WO2019014652A1 (en) * 2017-07-13 2019-01-17 Memphis Meats, Inc. COMPOSITIONS AND METHODS FOR INCREASING THE EFFICACY OF CELL CULTURES USED IN FOOD PRODUCTION
AU2019336940B2 (en) 2018-09-06 2025-09-11 Bavarian Nordic A/S Storage improved poxvirus compositions
FR3089789B1 (fr) 2018-12-14 2022-05-27 Univ Claude Bernard Lyon Production de vaccins viraux sur une lignee cellulaire aviaire
EP3842065A1 (de) 2019-12-23 2021-06-30 Transgene Verfahren zum entwurf eines rekombinanten pockenvirus für einen therapeutischen impfstoff
JP7712284B2 (ja) 2020-03-12 2025-07-23 バヴァリアン・ノルディック・アクティーゼルスカブ ポックスウイルスの安定性を改善する組成物
CN116322740A (zh) 2020-07-13 2023-06-23 特兰斯吉恩股份有限公司 免疫抑制的治疗
WO2023213764A1 (en) 2022-05-02 2023-11-09 Transgene Fusion polypeptide comprising an anti-pd-l1 sdab and a member of the tnfsf
WO2023213763A1 (en) 2022-05-02 2023-11-09 Transgene Poxvirus encoding a binding agent comprising an anti- pd-l1 sdab
WO2023240152A1 (en) 2022-06-07 2023-12-14 Upside Foods, Inc. Engineering cell lines capable of proliferation in growth factor free media formulations

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002300900A (ja) * 2001-04-05 2002-10-15 National Institute Of Advanced Industrial & Technology 腫瘍悪性化因子および腫瘍悪性化を抑制する化合物のスクリーニング方法
EP1447443A4 (de) 2001-10-31 2006-06-07 Renomedix Inst Inc Immortalisierte mesenchymzellen und ihre verwendung
JP3897717B2 (ja) 2002-04-23 2007-03-28 オリンパス株式会社 細胞移植治療材料およびその製造方法
PL1979474T3 (pl) * 2006-01-05 2011-01-31 Transgene Sa Ptasia odwrotna transkryptaza o charakterze telomerazy

Also Published As

Publication number Publication date
US9024003B2 (en) 2015-05-05
CY1110860T1 (el) 2015-06-10
AU2007204024A1 (en) 2007-07-12
CA2636329C (en) 2016-12-13
KR20080085074A (ko) 2008-09-22
WO2007077256A1 (en) 2007-07-12
AU2007204024B2 (en) 2012-01-19
RU2008125815A (ru) 2010-02-10
RU2415867C2 (ru) 2011-04-10
BRPI0706836B1 (pt) 2021-05-25
JP2013027397A (ja) 2013-02-07
US20100173378A1 (en) 2010-07-08
EP1979474A1 (de) 2008-10-15
HK1122069A1 (en) 2009-05-08
SI1979474T1 (sl) 2010-10-29
RS51525B (sr) 2011-06-30
CN102268413A (zh) 2011-12-07
KR101337377B1 (ko) 2013-12-09
EP1979474B1 (de) 2010-08-11
JP2009521945A (ja) 2009-06-11
JP5661243B2 (ja) 2015-01-28
DE602007008360D1 (de) 2010-09-23
PL1979474T3 (pl) 2011-01-31
BRPI0706836A2 (pt) 2011-04-05
DK1979474T3 (da) 2010-09-20
HRP20100484T1 (hr) 2010-10-31
CA2636329A1 (en) 2007-07-12
PT1979474E (pt) 2010-10-22
WO2007077256B1 (en) 2007-10-25

Similar Documents

Publication Publication Date Title
ATE477321T1 (de) Aviäre telomerase reverse transkriptase
ATE502122T1 (de) Chemisch modifizierte oligonukleotidprimer zur nukleinsäureamplifikation
DE602006018709D1 (de) Estergebundene geminitensidverbindungen zur verwendung in der gentherapie
MX2010001490A (es) Acidos nucleicos de enlace sdf-1 y uso de los mismos.
WO2015112767A3 (en) Novel reverse transcriptases for use in high temperature nucleic acid synthesis
MX2020003168A (es) Pirimidinas modificadas en la posicion 5 y su uso.
MX2014007233A (es) Composiciones de nucleosidos, nucleotidos y acidos nucleicos modificados.
EA201071320A1 (ru) Активаторы глюкокиназы
BR112014032316A2 (pt) proteínas de repetição de anquirina projetadas que se ligam ao fator de crescimento derivado de plaqueta
DE112007001307A5 (de) Mikrobiologische Herstellung von 3-Hydroxyisobuttersäure
EA200970580A1 (ru) Таннат разагилина
EA201391632A1 (ru) Аминокислотные последовательности, направленные против il-17a, il-17f и/или il-17a/f, и содержащие их полипептиды
BR112012015740A2 (pt) anticorpos de anti-flt3 e metodos de uso dos mesmos
EA200870514A1 (ru) Ацетиленовые гетероарильные соединения
WO2011106629A3 (en) Modified proteins and methods of making and using same
EA201171220A1 (ru) Мутанты fgf21 и их применение
GT200600112A (es) Composiciiones de tigeciclina y metodos de preparacion
MX385926B (es) Proteínas de fusión de citoquinas.
UA105914C2 (uk) Синтез стирилпіридину, міченого радіоізотопом 18f, з тозилатного прекурсора та стабільна фармацевтична композиція на його основі
BRPI0613770A2 (pt) anticorpos anti-cd26 e métodos de uso destes
EA200870515A1 (ru) Моноциклические гетероарильные соединения
EA200970472A1 (ru) Замещенные пиразолы, композиции, их содержащие, способ получения и применение
ATE478858T1 (de) Cyclische sulfone, die zur verwendung als bace- inhibitoren geeignet sind
ATE517900T1 (de) Heptarylen-und octarylentetracarbonsäurediimide und deren herstellung
ATE542915T1 (de) Cst-ii-modifzierungen für erhöhte proteinexpression